HNF1A and HNF4A mutations are associated with prolonged half-life of glibenclamide but not glipizide in human MODY subjects

被引：0
|
作者：
Urbanova, J. [1 ,2 ]
Andel, M. [1 ,2 ]
机构：
[1] Ctr Res Diabet Metab & Nutr, Dept Internal Med 2, Prague, Czech Republic
[2] Charles Univ Prague, Fac Med 3, Prague, Czech Republic
来源：
DIABETOLOGIA | 2014年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
810
引用
收藏
页码：S327 / S327
页数：1
相关论文
共 50 条
  • [1] HNF1A and HNF4A Mutations Cause Prolonged Half-life of Glibenclamide but Not Glipizide in Human MODY Subjects
    Urbanova, Jana
    DIABETES, 2014, 63 : A277 - A277
  • [2] Half-Life of Sulfonylureas in HNF1A and HNF4A Human MODY Patients is not Prolonged as Suggested by the Mouse Hnf1a-/- Model
    Urbanova, Jana
    Andel, Michal
    Potockova, Jana
    Klima, Josef
    Macek, Jan
    Ptacek, Pavel
    Mat'oska, Vaclav
    Kumstyrova, Tereza
    Heneberg, Petr
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (39) : 5736 - 5748
  • [3] Novel Presentations of Congenital Hyperinsulinism due to Mutations in the MODY genes: HNF1A and HNF4A
    Stanescu, Diana E.
    Hughes, Nkecha
    Kaplan, Bernard
    Stanley, Charles A.
    De Leon, Diva D.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (10): : E2026 - E2030
  • [4] GCK, HNF1A and HNF4A variant analysis in suspected MODY patients
    Zemeckiene, Zivile
    Sukys, Marius
    Jonikas, Rimvydas
    Nasvytiene, Inga
    Valanciute, Inga
    Poceviciene, Inga
    Ugenskiene, Rasa
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2022, 30 (SUPPL 1) : 148 - 149
  • [5] Double Heterozygous Mutations Involving Both HNF1A/MODY3 and HNF4A/MODY1 Genes
    Forlani, Gabriele
    Zucchini, Stefano
    Di Rocco, Antonio
    Di Luzio, Raffaella
    Scipione, Mirella
    Marasco, Elena
    Romeo, Giovanni
    Marchesini, Giulio
    Mantovani, Vilma
    DIABETES CARE, 2010, 33 (11) : 2336 - 2338
  • [6] Clinical heterogeneity of hyperinsulinism due to HNF1A and HNF4A mutations
    Tung, Joanna Yuet-ling
    Boodhansingh, Kara
    Stanley, Charles A.
    De Leon, Diva D.
    PEDIATRIC DIABETES, 2018, 19 (05) : 910 - 916
  • [7] Lack of mutations of HNF1A genes, HNF4A and INS in ten Tunisian patients with MODY type diabetes
    Amara, A.
    Ghezail, H.
    Brahem, R.
    Gribaa, M.
    Philippe, J.
    Dechaume, A.
    Saad, A.
    Chadli-Chaieb, M.
    Chaieb, L.
    Froguel, P.
    Vaxillaire, M.
    DIABETES & METABOLISM, 2011, 37 : A64 - A65
  • [8] MODY genes HNF1A, GCK and HNF4A pathogenic variant spectrum in pediatric patients
    Sukys, M.
    Asmoniene, V.
    Traberg, R.
    Cereskevicius, D.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1262 - 1263
  • [9] De novo mutations of GCK, HNF1A and HNF4A may be more frequent in MODY than previously assumed
    Stanik, Juraj
    Dusatkova, Petra
    Cinek, Ondrej
    Valentinova, Lucia
    Huckova, Miroslava
    Skopkova, Martina
    Dusatkova, Lenka
    Stanikova, Daniela
    Pura, Mikulas
    Klimes, Iwar
    Lebl, Jan
    Gasperikova, Daniela
    Pruhova, Stepanka
    DIABETOLOGIA, 2014, 57 (03) : 480 - 484
  • [10] De novo mutations of GCK, HNF1A and HNF4A may be more frequent in MODY than previously assumed
    Juraj Stanik
    Petra Dusatkova
    Ondrej Cinek
    Lucia Valentinova
    Miroslava Huckova
    Martina Skopkova
    Lenka Dusatkova
    Daniela Stanikova
    Mikulas Pura
    Iwar Klimes
    Jan Lebl
    Daniela Gasperikova
    Stepanka Pruhova
    Diabetologia, 2014, 57 : 480 - 484
12345